e-Drug3D 805 |
BRINZOLAMIDE
|
cas 138890-62-7 |
CLASS SENSORY |
ROUTE (list) OPHTHALMIC |
PK parameters Tmax 1 HOUR Solubility INSOLUBLE IN WATER |
Target TARGET CARBONIC ANHYDRASE II PDB Ligand code = BZ1 (link to the list of PDB complexes) Download experimental 3D coordinates of BZ1 with added hydrogens |
DrugCentral Carbonic anhydrase 2 UNIPROT P00918 CA2 |
Download SDF file | (4R)-4-ethylamino-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[4,5-e]thiazine-6-sulfonamide Formula: Calculated chemical properties: MW 383.53 NB_atoms 23 XLogP 0.09 PSA 122.617 NB_HD 3 NB_HA 8 fsp3 0.67 Lipinski(0=no;1=yes) 1 |
FDA NDA 020816 (pdf not found) INN (BRINZOLAMIDE) AZOPT (SANDOZ) APPROVAL= AP YEAR= 1998 NDA 204251 (pdf not found) INN (BRIMONIDINE TARTRATE ; BRINZOLAMIDE) SIMBRINZA (ALCON LABS INC) APPROVAL= AP YEAR= 2013 NDA 209406 (pdf not found) INN (BRINZOLAMIDE) BRINZOLAMIDE (WATSON LABS INC) APPROVAL= AP YEAR= 2020 NDA 204884 (pdf not found) INN (BRINZOLAMIDE) BRINZOLAMIDE (BAUSCH AND LOMB) APPROVAL= AP YEAR= 2021 NDA 211914 (pdf not found) INN (BRINZOLAMIDE) BRINZOLAMIDE (PADAGIS US) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 212137 (pdf not found) INN (BRINZOLAMIDE ; BRIMONIDINE TARTRATE) BRINZOLAMIDE; BRIMONIDINE TARTRATE (PERRIGO PHARMA INTERNATIONAL DAC) APPROVAL= TA YEAR= 2023 |
Other links: |